Literature DB >> 33890285

Historical and new insights into pathogenesis of type 1 diabetes (2).

F S Wong1, T I Tree2.   

Abstract

In this second and final part of the collection of articles for the Immunology of Diabetes Society review series on insights into pathogenesis of type 1 diabetes, we present two articles. The first of these covers a debate that took place in the Immunology of Diabetes Society meeting in London 2018, in which five investigators presented a case for specific immune cells/targets to be the 'Achilles Heel of type 1 diabetes'. The second article presents further insights into the generation of post-translationally modified peptides. It focuses upon mechanisms and processes that lead to new potentially autoantigenic targets for CD8+ T cells, and complements the review of new hybrid peptide targets for CD4+ T cells in the first part of our series.
© 2021 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33890285      PMCID: PMC8062994          DOI: 10.1111/cei.13597

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

Review 1.  HIPs and HIP-reactive T cells.

Authors:  T A Wiles; T Delong
Journal:  Clin Exp Immunol       Date:  2019-06-17       Impact factor: 4.330

Review 2.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

Review 3.  Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.

Authors:  L Peters; A Posgai; T M Brusko
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

4.  Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.

Authors:  Emily K Sims; Brian N Bundy; Kenneth Stier; Elisavet Serti; Noha Lim; S Alice Long; Susan M Geyer; Antoinette Moran; Carla J Greenbaum; Carmella Evans-Molina; Kevan C Herold
Journal:  Sci Transl Med       Date:  2021-03-03       Impact factor: 17.956

Review 5.  Spliced HLA-bound peptides: a Black Swan event in immunology.

Authors:  P Faridi; M Dorvash; A W Purcell
Journal:  Clin Exp Immunol       Date:  2021-03-28       Impact factor: 4.330

Review 6.  Birth and coming of age of islet autoantibodies.

Authors:  E Bonifacio; P Achenbach
Journal:  Clin Exp Immunol       Date:  2019-09-12       Impact factor: 4.330

Review 7.  Evolving Antibody Therapies for the Treatment of Type 1 Diabetes.

Authors:  Qi Ke; Charles J Kroger; Matthew Clark; Roland M Tisch
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

Review 8.  Presumption of guilt for T cells in type 1 diabetes: lead culprits or partners in crime depending on age of onset?

Authors:  Alexia Carré; Sarah J Richardson; Etienne Larger; Roberto Mallone
Journal:  Diabetologia       Date:  2020-10-21       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.